Sodium phosphate does not increase risk for acute kidney injury after routine colonoscopy, compared with polyethylene glycol

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 9, 2014, Pages

  Layton, J Bradley ^a   Klemmer, Philip J ^b   Christiansen, Christian F ^c   Bomback, Andrew S ^d   Baron, John A ^b   Sandler, Robert S ^b   Kshirsagar, Abhijit V ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d NONE   (United States)

Author keywords

Bowel preparations; Comparative safety; Endoscopy; Pharmacoepidemiology

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; MACROGOL; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; SODIUM DIHYDROGEN PHOSPHATE; THIAZIDE DIURETIC AGENT; LAXATIVE; MACROGOL DERIVATIVE; PHOSPHATE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COLON LAVAGE; COLONOSCOPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIURETIC THERAPY; FEMALE; FOOD AND DRUG ADMINISTRATION; HAZARD RATIO; HEALTH INSURANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; OUTCOME ASSESSMENT; OUTPATIENT; PREDICTIVE VALUE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; ADVERSE EFFECTS; CHEMICALLY INDUCED; MIDDLE AGED; PREOPERATIVE CARE; PROCEDURES; RISK ASSESSMENT; UNITED STATES; END STAGE RENAL DISEASE; ENDOSCOPY; FOLLOW UP; INTESTINE PREPARATION; KIDNEY FAILURE; KIDNEY INJURY; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; POPULATION; RHABDOMYOLYSIS;

ACUTE KIDNEY INJURY; AGED; CATHARTICS; COHORT STUDIES; COLONOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHATES; POLYETHYLENE GLYCOLS; PREOPERATIVE CARE; RISK ASSESSMENT; UNITED STATES;

EID: 84906789882     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.01.034     Document Type: Article

References (37)

1. Patel V., Emmett M., Santa Ana C.A., et al. Pathogenesis of nephrocalcinosis after sodium phosphate catharsis to prepare for colonoscopy: intestinal phosphate absorption and its effect on urine mineral and electrolyte excretion. Hum Pathol 2007, 38:193-194. author reply 194-195.
2. Biberstein M., Parker B.A. Enema-induced hyperphosphatemia. Am J Med 1985, 79:645-646.
3. Korzets A., Dicker D., Chaimoff C., et al. Life-threatening hyperphosphatemia and hypocalcemic tetany following the use of fleet enemas. JAm Geriatr Soc 1992, 40:620-621.
4. Vukasin P., Weston L.A., Beart R.W. Oral Fleet Phospho-Soda laxative-induced hyperphosphatemia and hypocalcemic tetany in an adult: report of a case. Dis Colon Rectum 1997, 40:497-499.
5. Desmeules S., Bergeron M.J., Isenring P. Acute phosphate nephropathy and renal failure. NEngl J Med 2003, 349:1006-1007.
6. Markowitz G.S., Nasr S.H., Klein P., et al. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol 2004, 35:675-684.
7. Markowitz G.S., Stokes M.B., Radhakrishnan J., et al. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. JAm Soc Nephrol 2005, 16:3389-3396.
8. Connor A., Sykes L., Roberts I.S., et al. Acute phosphate nephropathy after sodium phosphate preparations. BMJ 2008, 337:a182.
9. Ori Y., Herman M., Tobar A., et al. Acute phosphate nephropathy-an emerging threat. Am J Med Sci 2008, 336:309-314.
10. Brunelli S.M. Association between oral sodium phosphate bowel preparations and kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 53:448-456.
11. Hurst F.P., Bohen E.M., Osgard E.M., et al. Association of oral sodium phosphate purgative use with acute kidney injury. JAm Soc Nephrol 2007, 18:3192-3198.
12. Russmann S., Lamerato L., Motsko S.P., et al. Risk of further decline in renal function after the use of oral sodium phosphate or polyethylene glycol in patients with a preexisting glomerular filtration rate below 60 ml/min. Am J Gastroenterol 2008, 103:2707-2716.
13. Khurana A., McLean L., Atkinson S., et al. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med 2008, 168:593-597.
14. Ehrenpreis E.D., Parakkal D., Semer R., et al. Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration. Colorectal Dis 2011, 13:e270-e275.
15. Russmann S., Lamerato L., Marfatia A., et al. Risk of impaired renal function after colonoscopy: a cohort study in patients receiving either oral sodium phosphate or polyethylene glycol. Am J Gastroenterol 2007, 102:2655-2663.
16. Singal A.K., Rosman A.S., Post J.B., et al. The renal safety of bowel preparations for colonoscopy: a comparative study of oral sodium phosphate solution and polyethylene glycol. Aliment Pharmacol Ther 2008, 27:41-47.
17. Abaskharoun R., Depew W., Vanner S. Changes in renal function following administration of oral sodium phosphate or polyethylene glycol for colon cleansing before colonoscopy. Can J Gastroenterol 2007, 21:227-231.
18. Brunelli S.M., Lewis J.D., Gupta M., et al. Risk of kidney injury following oral phosphosoda bowel preparations. JAm Soc Nephrol 2007, 18:3199-3205.
19. Seol D.C., Hong S.N., Kim J.H., et al. Change in renal function after sodium phosphate preparation for screening colonoscopy. World J Gastroenterol 2010, 16:2010-2016.
20. Johanson J.F., Popp J.W., Cohen L.B., et al. Arandomized, multicenter study comparing the safety and efficacy of sodium phosphate tablets with 2L polyethylene glycol solution plus bisacodyl tablets for colon cleansing. Am J Gastroenterol 2007, 102:2238-2246.
21. FDA requires new safety measures for oral sodium phosphate products to reduce risk of acute kidney injury risk associated with both prescription and over-the-counter (OTC) products. Volume 2013 2008, US Food and Drug Administration, Silver Spring, MD.
22. Brunelli S.M., Feldman H.I., Latif S.M., et al. Acomparison of sodium phosphosoda purgative to polyethylene glycol bowel preparations prior to colonoscopy. Fam Med 2009, 41:39-45.
23. Juluri R., Eckert G., Imperiale T.F. Polyethylene glycol vs. sodium phosphate for bowel preparation: a treatment arm meta-analysis of randomized controlled trials. BMC Gastroenterol 2011, 11:38.
24. Juluri R., Eckert G., Imperiale T.F. Meta-analysis: randomized controlled trials of 4-L polyethylene glycol and sodium phosphate solution as bowel preparation for colonoscopy. Aliment Pharmacol Ther 2010, 32:171-181.
25. Belsey J., Crosta C., Epstein O., et al. Meta-analysis: the relative efficacy of oral bowel preparations for colonoscopy 1985-2010. Aliment Pharmacol Ther 2012, 35:222-237.
26. Lawrance I.C., Willert R.P., Murray K. Bowel cleansing for colonoscopy: prospective randomized assessment of efficacy and of induced mucosal abnormality with three preparation agents. Endoscopy 2011, 43:412-418.
27. Parsons L.S. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Twenty-Sixth Annual SAS® Users Group International Conference 2001, SAS Institute, Inc, Cary, NC.
28. Nordin B.E.C. Urinary excretion. Calcium, phosphate, and magnesium metabolism: clinical physiology and diagnostic procedures 1976, Longman Group Limited, New York.
29. Patel V., Nicar M., Emmett M., et al. Intestinal and renal effects of low-volume phosphate and sulfate cathartic solutions designed for cleansing the colon: pathophysiological studies in five normal subjects. Am J Gastroenterol 2009, 104:953-965.
30. Winkelmayer W.C., Schneeweiss S., Mogun H., et al. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis 2005, 46:225-232.
31. Vlasschaert M.E., Bejaimal S.A., Hackam D.G., et al. Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis 2011, 57:29-43.
32. Kaufman J., Dhakal M., Patel B., et al. Community-acquired acute renal failure. Am J Kidney Dis 1991, 17:191-198.
33. Feest T.G., Round A., Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993, 306:481-483.
34. Liano F., Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996, 50:811-818.
35. Obialo C.I., Okonofua E.C., Tayade A.S., et al. Epidemiology of de novo acute renal failure in hospitalized African Americans: comparing community-acquired vs hospital-acquired disease. Arch Intern Med 2000, 160:1309-1313.
36. Greenland S., Lash T.L. Bias analysis. Modern epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia, PA. 3rd ed. K.J. Rothman, S. Greenland, T.L. Lash (Eds.).
37. Chubak J., Pocobelli G., Weiss N.S. Tradeoffs between accuracy measures for electronic health care data algorithms. JClin Epidemiol 2012, 65:343-349.e2.